Re-irradiation for head and neck squamous cell carcinoma

Area of Science:

• Oncology
• Head and Neck Surgery
• Radiation Oncology

Background:

• Local recurrences of head and neck squamous cell carcinoma after initial curative treatment pose a significant clinical challenge.
• Salvage options like surgery or re-irradiation are critical for potentially curative management.

Purpose of the Study:

• To review prognostic factors, re-irradiation techniques, and outcomes for recurrent head and neck squamous cell carcinoma.
• To evaluate the role of salvage surgery and re-irradiation in managing recurrent disease.

Main Methods:

• A PubMed literature review was conducted using keywords: squamous cell carcinoma, recurrent, re-irradiation, and prognostic factors.
• Articles were selected based on their relevance to prognostic factors, re-irradiation, and outcomes in recurrent head and neck squamous cell carcinoma.

Main Results:

• Multiple factors (age, performance status, recurrence time, radiation dose, recurrence site, chemotherapy use) influence outcomes.
• Salvage surgery is viable for a select patient subgroup.
• Re-irradiation, utilizing modern technology, is safe and offers significant, durable survival benefits, with a median survival of 10-12 months.
• Chemotherapy can be integrated with re-irradiation.

Conclusions:

• Personalized treatment strategies are essential for recurrent head and neck squamous cell carcinoma.
• Salvage surgery should be performed whenever feasible.
• Re-irradiation is a crucial therapeutic option for patients ineligible for surgery, particularly those with limited recurrence volume.